<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="(RMSF) and root mean square deviation (RMSD) values for backbone," exact="alpha" post="carbon and heavy atoms were recorded. For more accuracy,"/>
 <result pre="1. According to best binding affinities, Simeprevir, Ergotamine, Bromocriptine and" exact="Tadalafil" post="are selected for further analysis (Figure 2). Remdesivir and"/>
 <result pre="with SARS-CoV-2 Mpro. Drug Binding affinity (kcal/mol) GOLD fitting score" exact="Simeprevir" post="â€&quot;10.3 73.83 ZINC000164760756 Ergotamine â€&quot;9.8 81.8 ZINC000052955754 Bromocriptine â€&quot;9.6"/>
 <result pre="Binding affinity (kcal/mol) GOLD fitting score Simeprevir â€&quot;10.3 73.83 ZINC000164760756" exact="Ergotamine" post="â€&quot;9.8 81.8 ZINC000052955754 Bromocriptine â€&quot;9.6 70.66 ZINC000053683151 Tadalafil â€&quot;9.5"/>
 <result pre="73.83 ZINC000164760756 Ergotamine â€&quot;9.8 81.8 ZINC000052955754 Bromocriptine â€&quot;9.6 70.66 ZINC000053683151" exact="Tadalafil" post="â€&quot;9.5 59.32 ZINC000003993855 Dihydroergotamine â€&quot;9.2 75.46 ZINC000003978005 Perampanel â€&quot;9.2"/>
 <result pre="81.8 ZINC000052955754 Bromocriptine â€&quot;9.6 70.66 ZINC000053683151 Tadalafil â€&quot;9.5 59.32 ZINC000003993855" exact="Dihydroergotamine" post="â€&quot;9.2 75.46 ZINC000003978005 Perampanel â€&quot;9.2 74.57 ZINC000030691797 Nilotinib â€&quot;9.2"/>
 <result pre="70.66 ZINC000053683151 Tadalafil â€&quot;9.5 59.32 ZINC000003993855 Dihydroergotamine â€&quot;9.2 75.46 ZINC000003978005" exact="Perampanel" post="â€&quot;9.2 74.57 ZINC000030691797 Nilotinib â€&quot;9.2 84.77 ZINC000006716957 Rolapitant â€&quot;9.1"/>
 <result pre="59.32 ZINC000003993855 Dihydroergotamine â€&quot;9.2 75.46 ZINC000003978005 Perampanel â€&quot;9.2 74.57 ZINC000030691797" exact="Nilotinib" post="â€&quot;9.2 84.77 ZINC000006716957 Rolapitant â€&quot;9.1 72.66 ZINC000003816514 Naldemedine â€&quot;8.9"/>
 <result pre="84.77 ZINC000006716957 Rolapitant â€&quot;9.1 72.66 ZINC000003816514 Naldemedine â€&quot;8.9 70.68 ZINC000100378061" exact="Irinotecan" post="ZINC000001612996 â€&quot;8.9 72.3 Raltegravir â€&quot;8.9 64.33 ZINC000013831130 Lumacaftor â€&quot;8.8"/>
 <result pre="64.33 ZINC000013831130 Lumacaftor â€&quot;8.8 68.84 ZINC000064033452 Eltrombopag â€&quot;8.8 69.34 ZINC000011679756" exact="Saquinavir" post="â€&quot;8.7 87.79 ZINC000003914596 Sildenafil â€&quot;8.7 80.21 ZINC000019796168 Pimozide â€&quot;8.6"/>
 <result pre="69.34 ZINC000011679756 Saquinavir â€&quot;8.7 87.79 ZINC000003914596 Sildenafil â€&quot;8.7 80.21 ZINC000019796168" exact="Pimozide" post="â€&quot;8.6 77.44 ZINC000004175630 Paliperidone â€&quot;8.5 62.18 ZINC000004214700 Suvorexant â€&quot;8.5"/>
 <result pre="87.79 ZINC000003914596 Sildenafil â€&quot;8.7 80.21 ZINC000019796168 Pimozide â€&quot;8.6 77.44 ZINC000004175630" exact="Paliperidone" post="â€&quot;8.5 62.18 ZINC000004214700 Suvorexant â€&quot;8.5 62.23 ZINC000049036447 Nintedanib â€&quot;8.5"/>
 <result pre="77.44 ZINC000004175630 Paliperidone â€&quot;8.5 62.18 ZINC000004214700 Suvorexant â€&quot;8.5 62.23 ZINC000049036447" exact="Nintedanib" post="â€&quot;8.5 79.48 ZINC000100014909 Maraviroc â€&quot;8.5 74.25 ZINC000100003902 Paliperidone â€&quot;8.4"/>
 <result pre="62.23 ZINC000049036447 Nintedanib â€&quot;8.5 79.48 ZINC000100014909 Maraviroc â€&quot;8.5 74.25 ZINC000100003902" exact="Paliperidone" post="â€&quot;8.4 58.75 ZINC000001481956 Conivaptan â€&quot;8.4 69.76 ZINC000012503187 Pazopanib â€&quot;8.4"/>
 <result pre="58.75 ZINC000001481956 Conivaptan â€&quot;8.4 69.76 ZINC000012503187 Pazopanib â€&quot;8.4 66.93 ZINC000011617039" exact="Ibrutinib" post="â€&quot;8.4 76.69 ZINC000035328014 Tipranavir â€&quot;8.4 79.31 ZINC000100022637 Dabrafenib ZINC000068153186"/>
 <result pre="69.76 ZINC000012503187 Pazopanib â€&quot;8.4 66.93 ZINC000011617039 Ibrutinib â€&quot;8.4 76.69 ZINC000035328014" exact="Tipranavir" post="â€&quot;8.4 79.31 ZINC000100022637 Dabrafenib ZINC000068153186 â€&quot;8.3 68.28 Telotristat â€&quot;8.3"/>
 <result pre="66.93 ZINC000011617039 Ibrutinib â€&quot;8.4 76.69 ZINC000035328014 Tipranavir â€&quot;8.4 79.31 ZINC000100022637" exact="Dabrafenib" post="ZINC000068153186 â€&quot;8.3 68.28 Telotristat â€&quot;8.3 74.89 ZINC000084758235 Teniposide â€&quot;8.2"/>
 <result pre="79.31 ZINC000100022637 Dabrafenib ZINC000068153186 â€&quot;8.3 68.28 Telotristat â€&quot;8.3 74.89 ZINC000084758235" exact="Teniposide" post="â€&quot;8.2 58.82 ZINC000004099009 Apixaban â€&quot;8.2 72.74 ZINC000011677837 Rifaximin â€&quot;7.7"/>
 <result pre="â€&quot;8.3 68.28 Telotristat â€&quot;8.3 74.89 ZINC000084758235 Teniposide â€&quot;8.2 58.82 ZINC000004099009" exact="Apixaban" post="â€&quot;8.2 72.74 ZINC000011677837 Rifaximin â€&quot;7.7 42.56 ZINC000169621200 Lifitegrast â€&quot;7.5"/>
 <result pre="74.89 ZINC000084758235 Teniposide â€&quot;8.2 58.82 ZINC000004099009 Apixaban â€&quot;8.2 72.74 ZINC000011677837" exact="Rifaximin" post="â€&quot;7.7 42.56 ZINC000169621200 Lifitegrast â€&quot;7.5 73.73 ZINC000084668739 Montelukast (Contini,"/>
 <result pre="72.74 ZINC000011677837 Rifaximin â€&quot;7.7 42.56 ZINC000169621200 Lifitegrast â€&quot;7.5 73.73 ZINC000084668739" exact="Montelukast" post="(Contini, 2020) â€&quot;8.3 93.62 GHRP-2 (Contini, 2020) â€&quot;8.1 95.49"/>
 <result pre="GHRP-2 (Contini, 2020) â€&quot;8.1 95.49 Indinavir (Contini, 2020) â€&quot;8 88.35" exact="Cobicistat" post="(Contini, 2020) â€&quot;7.5 86.53 Angiotensin II (Contini, 2020) â€&quot;6.9"/>
 <result pre="Ergotamine, (c) Bromocriptine, and (d) Tadalafil. Simeprevir, Ergotamine, Bromocriptine and" exact="Tadalafil" post="form a number of hydrogen bonds and hydrophobic interactions"/>
 <result pre="active site residues are categorized as hydrophobic (Table 2). Both" exact="Simeprevir" post="and Ergotamine form a hydrogen bond with at least"/>
 <result pre="residues are categorized as hydrophobic (Table 2). Both Simeprevir and" exact="Ergotamine" post="form a hydrogen bond with at least one of"/>
 <result pre="Câ€‰=â€‰Carbon Hydrogen bond. Interacting residue Distance Bond category Bond type" exact="Simeprevir" post="CYS145 2.7202 H CH GLN189 2.29 H CH GLY143"/>
 <result pre="Hydrophobic Pi-Alkyl ALA191 4.47775 Hydrophobic Pi-Alkyl PRO168 3.91598 Hydrophobic Pi-Alkyl" exact="Ergotamine" post="HIS41 2.88425 H C MET165 1.89419 H C MET165"/>
 <result pre="Pi-Alkyl GLN189 2.38092 Hydrophobic Pi-Sigma HIS41 5.13653 Hydrophobic Pi-Pi-T Shaped" exact="Tadalafil" post="ASN142 2.16312 H C GLY143 2.66564 H C MET165"/>
 <result pre="Hydrophobic Pi-Alkyl MET49 4.6017 Hydrophobic Pi-Alkyl HIS41 5.18874 Hydrophobic Pi-Alkyl" exact="Simeprevir" post="is observed to show three hydrophobic interactions with Pro168,"/>
 <result pre="Leu50 and one with each of the Thr190 and Ala191." exact="Ergotamine" post="exhibits one piâ€&quot;alkyl and one piâ€&quot;pi T-shaped hydrophobic interaction"/>
 <result pre="one with each of the Met49, Cys145 and Gln189 residues." exact="Tadalafil" post="exhibits hydrophobic interactions with both catalytic residues. Both Ergotamine"/>
 <result pre="residues. Tadalafil exhibits hydrophobic interactions with both catalytic residues. Both" exact="Ergotamine" post="and Tadalafil show one piâ€&quot;sulfur interaction with Met165 and"/>
 <result pre="exhibits hydrophobic interactions with both catalytic residues. Both Ergotamine and" exact="Tadalafil" post="show one piâ€&quot;sulfur interaction with Met165 and Met49 residues,"/>
 <result pre="selected drugs and apoâ€&quot;form is performed for 100â€‰ns. RMSD of" exact="alpha" post="carbon atoms, RMSF of all amino acid residues, solvent"/>
 <result pre="over the phase of 100â€‰ns, (b) RMSF values of the" exact="alpha" post="carbon over the entire simulation, where the ordinate is"/>
 <result pre="apoâ€&quot;Mpro complex experienced a fluctuation in Rg value during 80â€&quot;90â€‰ns." exact="Ergotamine" post="showed structural compactness all over the simulation time with"/>
 <result pre="structure of Mpro is shown in beige color with (a)" exact="Simeprevir" post="(cyan), (b) Ergotamine (green), (c) Bromocriptine (blue) and (d)"/>
 <result pre="is shown in beige color with (a) Simeprevir (cyan), (b)" exact="Ergotamine" post="(green), (c) Bromocriptine (blue) and (d) Tadalafil (orange red)."/>
 <result pre="Simeprevir (cyan), (b) Ergotamine (green), (c) Bromocriptine (blue) and (d)" exact="Tadalafil" post="(orange red). 3.4. Principal components analysis PCA is applied"/>
 <result pre="apoâ€&quot;Mpro and Simeprevirâ€&quot;Mpro complex. Thus, by forming a complex with" exact="Ergotamine" post="and Tadalafil, Mpro showed a similar structural profile compared"/>
 <result pre="Therefore, it is evident from the PCA scoring plot that" exact="Simeprevir" post="has the best binding stability with Mpro, while Ergotamine"/>
 <result pre="that Simeprevir has the best binding stability with Mpro, while" exact="Ergotamine" post="and Tadalafil also demonstrate almost similar behavior in MD"/>
 <result pre="has the best binding stability with Mpro, while Ergotamine and" exact="Tadalafil" post="also demonstrate almost similar behavior in MD simulation. Figure"/>
 <result pre="(D2, D3 and D5) containing indole ring, amide group and" exact="alcohol" post="group are clustered together on the fourth quadrant of"/>
 <result pre="SARS-CoV-2. Among the 1615 studied drugs, Simeprevir, Ergotamine, Bromocriptine and" exact="Tadalafil" post="are found to have the highest binding affinity. As"/>
 <result pre="of the catalytic residues. Furthermore, MD simulations exhibit that Simeprevir," exact="Ergotamine" post="and Bromocriptine drugs with Mpro protein preserve the structural"/>
 <result pre="reveals that drugs containing an indole ring, amide group and" exact="alcohol" post="group are clustered together in the fourth quadrant and"/>
</results>
